[VIRTUAL] Prolonged overall survival (OS) in patients with metastatic colorectal cancer (mCRC) in SPICE, a phase I study of enadenotucirev in combination with nivolumab

Opdivo (nivolumab) - Ono Pharma, BMS

enadenotucirev (ColoAd1) - PsiOxus

https://jitc.bmj.com/content/8/Suppl_3/A355

Tom Lillie; Andrew Stone; Sarah Lockwood; Richard Brown; Andrew Fox; Eirini Bournazou; John Beadle

Oct 14, 2020